711 filings
Page 16 of 36
8-A12B
39r6kirwc 362ffk
5 Jan 21
Registration of securities on exchange
4:16pm
8-K
pkjsm bdims
5 Jan 21
Sven Guenther, Ph.D., our executive vice president, research and development; and Summary Compensation Table
9:10am
CORRESP
o24vd4
5 Jan 21
Correspondence with SEC
12:00am
CORRESP
8earen o87
5 Jan 21
Correspondence with SEC
12:00am
8-K
emy2gw3 hhmrx3k
28 Dec 20
Entry into a Material Definitive Agreement
6:15am
8-K
sjysxvof2kw cs
28 Dec 20
KemPharm Announces 1-for-16 Reverse Stock Split
12:00am
8-K
oyzux
21 Dec 20
Entry into a Material Definitive Agreement
6:06am
UPLOAD
om205n61 v8k4unj
2 Dec 20
Letter from SEC
12:00am
8-K/A
k91yai
23 Nov 20
KemPharm Provides Update on Development Pipeline
9:23pm
8-K
ir05tcn9
23 Nov 20
KemPharm Provides Update on Development Pipeline
4:54pm
DEFA14A
ueieb
23 Nov 20
Additional proxy soliciting materials
4:52pm
8-K
xvrp7cumj yzv
19 Nov 20
Submission of Matters to a Vote of Security Holders
12:00am
8-K/A
1l76cgu
30 Oct 20
KemPharm Reports Third Quarter 2020 Financial Results
12:00am
8-K
mfo1kw34hhpadg3
29 Oct 20
KemPharm Reports Third Quarter 2020 Financial Results
4:27pm
DEFA14A
ey73p
29 Oct 20
Additional proxy soliciting materials
4:25pm